Sunmax Biotechnology Co., Ltd. (TPEX:4728)

Sunmax Biotechnology Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	536.09	775.47	854.69	589.3	602.55	778.58
Short-Term Investments	200	90	107.1	227.37	76.79	131.01
Cash & Short-Term Investments	736.09	865.47	961.79	816.67	679.34	909.59
Cash Growth	12.64%	-10.02%	17.77%	20.21%	-25.31%	24.96%
Accounts Receivable	0.81	2.54	2.55	1.94	3.72	7.63
Other Receivables	7.06	26.07	6.84	1.37	4.71	2.88
Receivables	7.87	28.61	9.39	3.3	8.43	10.51
Inventory	158.6	157.36	93.67	73.79	54.74	25.33
Other Current Assets	27.86	41.08	14.08	11.81	45.06	20.09
Total Current Assets	930.41	1,093	1,079	905.58	787.57	965.53
Property, Plant & Equipment	895.83	939.2	904.32	604.39	485.56	277.18
Long-Term Investments	-	-	-	10.3	17.18	7.48
Other Intangible Assets	8.03	6.4	5.06	3.84	3.84	5.18
Long-Term Deferred Tax Assets	37.33	37.71	53.39	20.76	17.32	11.82
Other Long-Term Assets	27.17	19.15	117.33	248.41	172.55	96.93
Total Assets	1,899	2,095	2,159	1,793	1,484	1,364
Accounts Payable	9.17	18.27	11.98	21.77	14.95	7.18
Current Portion of Leases	24.23	23.28	24.24	13.27	32.28	24.69
Current Income Taxes Payable	47.7	67.76	89.03	82.94	70.84	29.13
Current Unearned Revenue	32.77	73.85	202.57	60.09	122.95	111.56
Other Current Liabilities	127.51	145.75	129.62	147.93	92.93	121.95
Total Current Liabilities	241.38	328.91	457.43	326	333.95	294.51
Long-Term Leases	99.62	121.94	144.78	49.82	66.9	105.27
Long-Term Deferred Tax Liabilities	87.06	103.06	105.19	57.16	22.16	39.4
Other Long-Term Liabilities	26.29	28.23	25.59	35.02	37.43	36.09
Total Liabilities	454.35	582.13	732.99	468	460.44	475.27
Common Stock	544.63	544.63	544.63	544.63	544.63	544.63
Additional Paid-In Capital	3.65	3.65	3.65	3.65	25.44	25.44
Retained Earnings	909.25	973.11	892.8	778.61	460.46	323.74
Comprehensive Income & Other	-13.1	-8.56	-15.04	-1.62	-6.95	-4.97
Total Common Equity	1,444	1,513	1,426	1,325	1,024	888.84
Shareholders' Equity	1,444	1,513	1,426	1,325	1,024	888.84
Total Liabilities & Equity	1,899	2,095	2,159	1,793	1,484	1,364
Total Debt	123.86	145.21	169.02	63.09	99.18	129.96
Net Cash (Debt)	612.24	720.26	792.78	753.58	580.16	779.64
Net Cash Growth	22.76%	-9.15%	5.20%	29.89%	-25.59%	27.61%
Net Cash Per Share	11.23	13.21	14.54	13.82	10.64	14.30
Filing Date Shares Outstanding	54.46	54.46	54.46	54.46	54.46	54.46
Total Common Shares Outstanding	54.46	54.46	54.46	54.46	54.46	54.46
Working Capital	689.04	763.6	621.51	579.57	453.62	671.02
Book Value Per Share	26.52	27.78	26.18	24.33	18.79	16.32
Tangible Book Value	1,436	1,506	1,421	1,321	1,020	883.66
Tangible Book Value Per Share	26.37	27.66	26.09	24.26	18.72	16.22
Land	64.9	64.9	-	-	-	-
Buildings	522.37	517.01	487.13	482.71	-	-
Machinery	332.51	343.25	293.4	82.42	62.95	98.43
Construction In Progress	5.44	0.3	17.79	-	331.26	86.92
Leasehold Improvements	43.22	45.44	44.01	44.79	44.4	44.82

Source: S&P Global Market Intelligence. Standard template. Financial Sources.